(@hitesh2710)
Hitesh Bhai – Few Q’s for which I would like to hear your views as they are from your domain:
- How good is the product portfolio of Novartis India Ltd?
- What kind of market opportunity do these drugs cater to? Business focus is on the four key disease areas- Mature Neurology, Transplant, Mature Oncology, and Bone & Pain.
- What will be the incentive for a doctor to prescribe these names compared to cheaper and branded alternatives (1mg shows various reputed names as cheaper alternatives)?
| Subscribe To Our Free Newsletter |
